BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 37 filers reported holding BRIDGEBIO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $341,487 | +23.1% | 450,000 | 0.0% | 0.00% | – |
| Q2 2023 | $277,344 | -3.6% | 450,000 | 0.0% | 0.00% | – |
| Q1 2023 | $287,726 | -84.9% | 450,000 | -90.9% | 0.00% | -100.0% |
| Q4 2022 | $1,909,606 | -11.5% | 4,950,000 | 0.0% | 0.00% | -25.0% |
| Q3 2022 | $2,158,000 | -36.9% | 4,950,000 | -41.4% | 0.00% | -33.3% |
| Q2 2022 | $3,422,000 | -22.5% | 8,450,000 | -10.6% | 0.01% | -14.3% |
| Q1 2022 | $4,418,000 | – | 9,450,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diameter Capital Partners LP | 52,257,000 | $39,745,106 | 8.72% |
| Context Capital Management, LLC | 32,083 | $24,052 | 1.93% |
| BRAIDWELL LP | 67,294,000 | $50,470,500 | 1.60% |
| DeepCurrents Investment Group LLC | 17,855,000 | $13,514,056 | 0.59% |
| Aequim Alternative Investments LP | 20,000,000 | $15,000,000 | 0.57% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 29,488,000 | $22,116,000 | 0.51% |
| SILVERBACK ASSET MANAGEMENT LLC | 5,000,000 | $3,750,375 | 0.51% |
| ARISTEIA CAPITAL, L.L.C. | 25,280,000 | $18,960,000 | 0.51% |
| SSI INVESTMENT MANAGEMENT LLC | 8,217,000 | $6,121,665 | 0.50% |
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,604,000 | $3,430,520 | 0.49% |